Trial intelligence / Profile preview

Fertility and Ovarian Reserve Post UAE during Cesarean Section

NCT02821702Completed

Sponsor
Sheba Medical Center
Start
Jul 2016
Primary completion
Dec 2019
Countries
1
01

Overview

Open-label trial, sponsored by Sheba Medical Center. Primary endpoints: Anti-Mullerian Hormone at 6 months and Antral Follicle Count at 6 months. Started Jul 2016; status: completed.

Beyond the preview

Go deeper on NCT02821702.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02821702.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call